Start Submission Become a Reviewer

Reading: Neoadjuvant chemotherapy and the complexity of operative procedure in advanced epithelial ov...

Download

A- A+
Alt. Display

Cohort Study

Neoadjuvant chemotherapy and the complexity of operative procedure in advanced epithelial ovarian cancer: a retrospective analysis

Authors:

Basel Refky,

Department of Surgical Oncology, Oncology Center Mansura University, EG
X close

Amr Elalfy,

Department of Surgical Oncology, Oncology Center Mansura University, EG
X close

Hanan Nabil,

Department of Obstetrics and Gynecology, Faculty of Medicine, University of Mansura, Mansura, EG
X close

Doaa El-Emam,

Department of Public Health, Faculty of Medicine, University of Mansura, Mansura, EG
X close

Khaled M. Abdelwahab,

Department of Surgical Oncology, Oncology Center Mansura University, EG
X close

Eduard Malik,

University Women’s Hospital, Klinikum Oldenburg, University of Oldenburg, Oldenburg, DE
X close

Amr A. Soliman

Universitätsklinik für Gynäkologie und Geburtshilfe, Klinikum Oldenburg AöR, Fakultät für Medizin und Gesundheitswissenschaften, Universität Oldenburg, Rahel-Straus-Straße 10, Oldenburg 26133, DE
About Amr A.

soliman.amr@klinikum-oldenburg.de

X close

Abstract

Introduction: Complete tumor resection for epithelial ovarian cancer (EOC) generally incorporates complex surgical maneuvers, especially bowel resection. This study retrospectively analyzed the impact of neoadjuvant chemotherapy (NAC) on complexity of surgical procedures for EOC (represented by bowel resection) and postoperative morbidity.

Methods: We retrospectively recruited all patients with Fédération Internationale de Gynécologie et d'Obstétrique (FIGO) stages IIIC–IVB EOC who were treated in our center between 2011 and 2016. Patients were divided into those who received primary debulking followed by chemotherapy (group A), and those who received NAC followed by interval debulking (group B). Patient age, tumor stage, grade, dates of commencement and completion of therapy, intraoperative events, completion of surgical resection, and postoperative events were evaluated.

Results: Of 92 patients, 42 were assigned to group A and 50 to group B. Their FIGO stages were group A—stages IIIC: 34 (80.9%), IVA: 6 (14.3%), and IVB: 2 (4.8%); and group B—stages IIIC: 45 (90%), IVA: 5 (10%), and IVB: 0 (0%). The 2 groups did not significantly differ in completeness of surgical cytoreduction or rates of bowel resection, intraoperative complications, or postoperative morbidities.

Conclusion: NAC did not reduce rates of bowel resection, intraoperative complications, and postoperative morbidity in advanced EOC compared with primary surgical cytoreduction. Future prospective studies will be required to corroborate our results.

How to Cite: Refky B, Elalfy A, Nabil H, El-Emam D, Abdelwahab KM, Malik E, et al.. Neoadjuvant chemotherapy and the complexity of operative procedure in advanced epithelial ovarian cancer: a retrospective analysis. International Journal of Surgery: Oncology. 2018;3(3):e59. DOI: http://doi.org/10.1097/IJ9.0000000000000059
2
Views
Published on 21 Feb 2018.
Peer Reviewed

Downloads

  • PDF (EN)